In conclusion, we uncovered key DEGs and molecular pathways altered in UHRF1-null cells using transcriptomics analysis, which offered insights into candidate adipogenesis regulators with therapeutic potential for metabolic diseases. Here, UHRF1 is linked to metabolic disease.